Skip to content

A Comparison of Tracheal Intubation Using the Totaltrack vs the Airtraq Laryngoscope in Routine Airway Management

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02395419
Enrollment
48
Registered
2015-03-23
Start date
2016-10-31
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endotracheal Intubation

Brief summary

Endotracheal intubation is usually required to allow unrestricted surgical approach. The Macintosh laryngoscope is the standard method. However in certain situations as difficult airway this technique is ineffective and poorly tolerated by the patient. Fiberoptic intubation is the gold standard in this scenario, however sometimes it is not possible due to failure or unavailability, so alternatives are needed. The TotalTrack (MedComflow SA, Barcelona, Spain) and the Airtraq (Prodol Meditec, Vizcaya, España) been designed specifically for the airway management. However, despite their use in clinical practice, there are no comparative studies.

Interventions

Sponsors

Manuel Ángel Gómez-Ríos
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing elective general anesthesia requiring OTI. * Patients duly informed and they have signed the informed consent during the pre-anesthetic consultation, or be sought after due meditation, expressing its consent to the inclusion in the study. * Age ≥18 years. * ASA I-III. * Sufficient intellectual capacity to understand the procedure and equipment used. * Do not submit predictors of difficult airway (Mallampati class III or IV; thyromental distance \<6 cm, sternomental distance \<12.5 cm, interincisal distance\<4.0 cm, bite test II or III, cervical mobility \<90 ° or history of difficult intubation). * Do not undergo thyroid surgery or present pharyngolaryngeal, glottic or cervical pathology * BMI \<30kg / m2 * Not presenting risk factors for aspiration * Not presenting respiratory disease, coronary or cerebral vascular. * Do not have a sore throat preoperative

Exclusion criteria

* Failure to meet the above criteria * Pregnancy * Allergy to any drug included in the protocol.

Design outcomes

Primary

MeasureTime frame
Total time of successful intubationTime of Orotracheal intubation (TOTI)

Secondary

MeasureTime frameDescription
percentage of glottic opening (POGO Score)TOTI
number of maneuversTOTI
Number of attempts of endotracheal intubationTOTI
Position taken by the anesthesiologist during orotracheal intubationTOTI
difficulty in intubation (IDS scale)TOTI
ComplicationsOTI and postintubation (24 hours)
endotracheal intubation success rate of each deviceTOTI
Degree of satisfactiontime of postintubation (ten minutes)Visual Analogic Scale
hemodinamic responseOTI pre and postintubation (time minutes)heart ratio, arterial pressure

Countries

Spain

Contacts

Primary ContactManuel G Gómez-Ríos, MD
magoris@hotmail.com+34636909413

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026